| Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8 (4), 445-544, 2012 | 13179* | 2012 |
| Correlation of circular RNA abundance with proliferation–exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues A Bachmayr-Heyda, AT Reiner, K Auer, N Sukhbaatar, S Aust, ... Scientific reports 5 (1), 8057, 2015 | 746 | 2015 |
| c-erbB-3: a nuclear protein in mammary epithelial cells M Offterdinger, C Schofer, K Weipoltshammer, TW Grunt The Journal of cell biology 157 (6), 929-940, 2002 | 250 | 2002 |
| Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, ... Journal of Experimental Medicine 216 (3), 688-703, 2019 | 173 | 2019 |
| Involvement of heregulin-β2 in the acquisition of the hormone-independent phenotype of breast cancer cells CK Tang, C Perez, T Grunt, C Waibel, C Cho, R Lupu Cancer research 56 (14), 3350-3358, 1996 | 167 | 1996 |
| Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? A Schulenburg, K Blatt, S Cerny-Reiterer, I Sadovnik, H Herrmann, ... Journal of hematology & oncology 8, 1-21, 2015 | 111 | 2015 |
| Overexpression of G protein‐coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma J Atamaniuk, A Gleiss, E Porpaczy, B Kainz, TW Grunt, M Raderer, ... European journal of clinical investigation 42 (9), 953-960, 2012 | 108 | 2012 |
| Interaction between fatty acid synthase-and ErbB-systems in ovarian cancer cells TW Grunt, R Wagner, M Grusch, W Berger, CF Singer, B Marian, ... Biochemical and biophysical research communications 385 (3), 454-459, 2009 | 106 | 2009 |
| Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells H Karlic, R Thaler, C Gerner, T Grunt, K Proestling, F Haider, F Varga Cancer genetics 208 (5), 241-252, 2015 | 102 | 2015 |
| Alternative splicing of fibroblast growth factor receptor IgIII loops in cancer K Holzmann, T Grunt, C Heinzle, S Sampl, H Steinhoff, N Reichmann, ... Journal of nucleic acids 2012, 2012 | 101 | 2012 |
| Activation of retinoic acid receptor α is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells SM Schneider, M Offterdinger, H Huber, TW Grunt Cancer research 60 (19), 5479-5487, 2000 | 101 | 2000 |
| Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells TW Grunt, M Saceda, MB Martin, R Lupu, E Dittrich, G Krupitza, H Harant, ... International journal of cancer 63 (4), 560-567, 1995 | 98 | 1995 |
| Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling T W Grunt, G L Mariani Current cancer drug targets 13 (2), 188-204, 2013 | 97 | 2013 |
| Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells D Veigel, R Wagner, G Stübiger, M Wuczkowski, M Filipits, R Horvat, ... International journal of cancer 136 (9), 2078-2090, 2015 | 82 | 2015 |
| Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer T Grunt, R Wagner US Patent App. 12/470,613, 2009 | 80 | 2009 |
| Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer K Tomek, R Wagner, F Varga, CF Singer, H Karlic, TW Grunt Molecular Cancer Research 9 (12), 1767-1779, 2011 | 78 | 2011 |
| Retinoic acid induced death of ovarian carcinoma cells correlates with c‐myc stimulation G Krupitza, W Hulla, H Harant, E Dittrich, E Kallay, H Huber, T Grunt, ... International journal of cancer 61 (5), 649-657, 1995 | 75 | 1995 |
| Interacting cancer machineries: cell signaling, lipid metabolism, and epigenetics TW Grunt Trends in Endocrinology & Metabolism 29 (2), 86-98, 2018 | 73 | 2018 |
| The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells C Brünner-Kubath, W Shabbir, V Saferding, R Wagner, CF Singer, ... Breast cancer research and treatment 129, 387-400, 2011 | 65 | 2011 |
| Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines S Tomek, W Koestler, P Horak, T Grunt, T Brodowicz, I Pribill, J Halaschek, ... European Journal of Cancer 39 (9), 1318-1329, 2003 | 65 | 2003 |
